The WHERE Study: Waiting for Hip and KneE REplacement (NCT06074900)
The WHERE Study: Waiting for Hip and KneE REplacement - A Prospective Cohort
π©Ί Plain-English Summary (8th-Grade Level)
Total hip and knee replacements (TJR) for osteoarthritis are common orthopaedic procedures performed in Canada. Waits for these procedures are already common and lengthy, and the COVID-19 pandemic has resulted in the further of delay of thousands of scheduled TJRs. Longer wait times for TJR can be associated with increased pain and functional disability, and up to 80% of patients awaiting TJR use opioids for pain management. Further, pre-operative pain, functional disability and opioid use has been linked to worse recovery and continued opioid abuse post-operatively. Interestingly, some clinical studies have shown that not all patients experience a deterioration in symptoms while on the waitlist for TJR, and a longer wait time is not always associated with poor post-operative outcomes. However, there is insufficient evidence surrounding the relationships between wait time, patient characteristics, and outcomes both prior to and following hip or knee replacement. The Investigators aim to establish a large prospective cohort of patients with osteoarthritis waiting for TJR with key research questions and the overarching objectives of identifying which patients deteriorate while on the waitlist, and how wait time affects patient-important outcomes following surgery. The study will enroll 3008 patients awaiting TJR at 10 Centres from across Canada. All participating site investigators are fellowship trained Orthopaedic surgeons, working in acute care facilities with active research programs and dedicated research staff. The study will follow the patients from their waitlist enrolment up to two years post-operatively. During this time, the research team will collect pain, function, opioid use, and quality of life measures at regular intervals. In addition, an economic analysis will be conducted to determine the impact of length of time on a waitlist on patient and healthcare system costs. The data will highlight the consequences of long waits for patients undergoing TJR, information that will improve patient care and provide insight for refining wait list policies.
Who can join: Review the eligibility criteria below.
Location: London Health Sciences Centre β London, Ontario
Age range: 18 Years
π§ͺ Interventions in This Study
- prospective cohort study (OTHER)
π "Do I Qualify?" β 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria β
π All Participating Trial Locations (1 Sites)
- London Health Sciences Centre β London, Ontario
π Contact the Study Coordinator
Phone: (519) 685-8500
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
π° Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA Β§ 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Hip Osteoarthritis
- Positioning for Hip Arthroscopic Surgery to Reduce Postoperative Numbness β Chicago, Illinois
- REDAPT Revision Hip System With RSA β Winnipeg, Manitoba
- Insigniaβ’ Hip Stem Outcomes Study β Phoenix, Arizona
- Prospective Catalystem CT-RSA β Winnipeg, Manitoba
- Alexis Retractor in Total Hip Arthroplasty β Miami, Florida
- Bone Marrow Aspirate Concentrate Versus Triamcinolone Injection For Hip Osteoarthritis β Weston, Florida
Explore by condition: All Hip Osteoarthritis clinical trials
π‘ How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.